(Q39417442)

11 September 2017

title

Safety of antileukotriene agents in asthma management (English)

1 reference

11 September 2017

0 references

S L Spector

1

1 reference

11 September 2017

Antileukotriene Working Group

series ordinal

2

1 reference

11 September 2017

publication date

1 June 2001

1 reference

Annals of Allergy, Asthma & Immunology

11 September 2017

published in

1 reference

11 September 2017

volume

86

1 reference

11 September 2017

issue

6 Suppl 1

1 reference

11 September 2017

page(s)

18-23

1 reference

Adverse effects of inhaled corticosteroids

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962307-1

7 January 2021

Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962307-1

7 January 2021

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962307-1

7 January 2021

Inhaled corticosteroids and cataract: prevalence, prevention and management

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962307-1

7 January 2021

Long-acting inhaled beta2-agonists in asthma therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962307-1

7 January 2021

Risks versus benefits of inhaled beta 2-agonists in the management of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962307-1

7 January 2021

Salmeterol xinafoate. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962307-1

7 January 2021

The use of beta-agonists and the risk of death and near death from asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962307-1

7 January 2021

The beta-agonist controversy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962307-1

7 January 2021

Theophylline. A review of its potential steroid sparing effects in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962307-1

7 January 2021

Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962307-1

7 January 2021

Leukotriene activity modulation in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962307-1

7 January 2021

Leukotriene-receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962307-1

7 January 2021

Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962307-1

7 January 2021

Churg-Strauss syndrome associated with zafirlukast

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962307-1

7 January 2021

Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962307-1

7 January 2021

Pulmonary eosinophilia associated with montelukast

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962307-1

7 January 2021

The American College of Rheumatology 1990 criteria for the classification of churg-strauss syndrome (allergic granulomatosis and angiitis)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962307-1

7 January 2021

Churg-Strauss Syndrome in Patients Receiving Montelukast as Treatment for Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962307-1

7 January 2021

Formes frustes of Churg-Strauss syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962307-1

7 January 2021

Steroids and Churg-Strauss syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962307-1

7 January 2021

10.1016/S1081-1206(10)62307-1

Identifiers

DOI

1 reference

11 September 2017

1 reference